Orme I M
Dept of Microbiology, Colorado State University, Fort Collins 80523, USA.
Trends Microbiol. 1995 Oct;3(10):401-4. doi: 10.1016/s0966-842x(00)88987-8.
The spectacular failure of the existing bacille Calmette-Guérin (BCG) vaccine in recent tuberculosis-control trials has prompted a search for potential replacements. Imaginative approaches currently under development include the modulation of BCG by the production of auxotrophic mutants or cytokine-secreting recombinants, and the development of subunit vaccines based on the major proteins of Mycobacterium tuberculosis.
现有卡介苗(BCG)疫苗在近期结核病控制试验中的惊人失败促使人们寻找潜在的替代疫苗。目前正在开发的创新方法包括通过生产营养缺陷型突变体或分泌细胞因子的重组体来改造卡介苗,以及开发基于结核分枝杆菌主要蛋白的亚单位疫苗。